Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Aug 2026, 13:38:15 UTC
Prior SEC filing
02 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Betsy Anne Seel, by Power of Attorney

Key filing fact

John Hancock Life & Health Insurance Co filed Form 4 for Manulife Private Credit Plus Fund on 25 Aug 2026.

Key facts

  • This page summarizes John Hancock Life & Health Insurance Co's Form 4 filing for Manulife Private Credit Plus Fund.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Aug 2026, 13:38.

Change

  • Previous filing in this sequence was filed on 02 Feb 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001962136 Primary reporting owner

John Hancock Life & Health Insurance Co

Relationship
Prior 10% Owner
Address
197 CLARENDON STREET, BOSTON
Signature
Betsy Anne Seel, by Power of Attorney
Signature date
25 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker transaction

Common Shares of Beneficial Interest

Sale

Transaction value
Shares
-110,165
Change %
-11%
Price
$19.97*
Shares after
880,125
Date
31 Mar 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

John Hancock Life & Health Insurance Co is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

SEC remarks

Form 4 is filed to report that the Reporting Person holds less than 10% of the securities of the Issuer, and therefore is no longer subject to Section 16 reporting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .